These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 10712083)

  • 1. [Symposium "Emerging Approaches to Cardiovascular Diseases: Detailed results and implications of the HOPE Study". Atlanta, 10. November 1999].
    Bischoff A
    Internist (Berl); 2000 Jan; 41(1):A24-7. PubMed ID: 10712083
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of ramipril in reducing sudden deaths and nonfatal cardiac arrests in high-risk individuals without heart failure or left ventricular dysfunction.
    Teo KK; Mitchell LB; Pogue J; Bosch J; Dagenais G; Yusuf S;
    Circulation; 2004 Sep; 110(11):1413-7. PubMed ID: 15353497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Experiences with the realisation of the innovative study designs using the example of the HOPE study -- concerning the contribution in DMW Supplement 2/2005].
    Traut V
    Dtsch Med Wochenschr; 2005 Nov; 130(47):2726; author reply 2727-8. PubMed ID: 16294292
    [No Abstract]   [Full Text] [Related]  

  • 4. A safe new dose of heart protection. Study shows drug can prevent attacks, strokes.
    Comarow A
    US News World Rep; 1999 Nov; 127(20):76. PubMed ID: 10623306
    [No Abstract]   [Full Text] [Related]  

  • 5. [Ramipril and new therapeutic possibilities for ACE-inhibitors].
    Vespasiani Gentilucci U; Picardi A
    Clin Ter; 2000; 151(4):307-8. PubMed ID: 11107682
    [No Abstract]   [Full Text] [Related]  

  • 6. Left ventricular hypertrophy: a "factor of risk": mass is reversible, but is the risk?
    Frohlich ED
    J Am Coll Cardiol; 2004 Jun; 43(12):2216-8. PubMed ID: 15193682
    [No Abstract]   [Full Text] [Related]  

  • 7. Diabetes and the HOPE study: implications for macrovascular and microvascular disease.
    Gerstein HC
    Int J Clin Pract Suppl; 2001 Jan; (117):8-12. PubMed ID: 11715357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [HOPE study].
    Katayama S
    Nihon Rinsho; 2006 Aug; 64 Suppl 6():475-9. PubMed ID: 16983779
    [No Abstract]   [Full Text] [Related]  

  • 9. [Preventive therapy with ACE inhibitors for coronary patients].
    Keltai M
    Orv Hetil; 2004 Feb; 145(9):461-5. PubMed ID: 15077477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What are 'tissue ACE inhibitors,' and should they be used instead of other ACE inhibitors?
    Francis GS; Gassler JP
    Cleve Clin J Med; 2001 Mar; 68(3):185-6. PubMed ID: 11263844
    [No Abstract]   [Full Text] [Related]  

  • 11. The prognostic significance of bundle branch block in high-risk chronic stable vascular disease patients: a report from the HOPE trial.
    Sumner G; Salehian O; Yi Q; Healey J; Mathew J; Al-Merri K; Al-Nemer K; Mann JF; Dagenais G; Lonn E;
    J Cardiovasc Electrophysiol; 2009 Jul; 20(7):781-7. PubMed ID: 19298567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Suboptimal results of Optimaal: treatment with ACE inhibitors remains the preferred therapy in patients with left ventricular dysfunction after acute myocardial infarct]].
    Danchin N
    Herz; 2002 Dec; 27(8):(18). PubMed ID: 12608391
    [No Abstract]   [Full Text] [Related]  

  • 13. Preventing stroke with ramipril. Superiority of particular class of antihypertensive agent remains to be shown.
    Yudkin JS
    BMJ; 2002 Aug; 325(7361):439. PubMed ID: 12201280
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effects of losartan, ramipril and their combination on left ventricular remodeling and function in spontaneous hypertensive rats].
    Xu R; Zhang Y; Zhang M; Li XC; Cai H; Chen WQ; Zhu H; Ge ZM; Zhang W
    Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(45):3199-204. PubMed ID: 16405840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attenuation of left ventricular dysfunction by an ACE inhibitor after myocardial infarction in a kininogen-deficient rat model.
    Koch M; Bonaventura K; Spillmann F; Dendorfer A; Schultheiss HP; Tschöpe C
    Biol Chem; 2008 Jun; 389(6):719-23. PubMed ID: 18627293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison between angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on the risk of myocardial infarction, stroke and death: a meta-analysis.
    Reboldi G; Angeli F; Cavallini C; Gentile G; Mancia G; Verdecchia P
    J Hypertens; 2008 Jul; 26(7):1282-9. PubMed ID: 18550998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zofenopril and ramipril and acetylsalicylic acid in postmyocardial infarction patients with left ventricular systolic dysfunction: a retrospective analysis in hypertensive patients of the SMILE-4 study.
    Borghi C; Ambrosioni E; Omboni S; Cicero AF; Bacchelli S; Esposti DD; Vinereanu D; Ambrosio G; Zava D;
    J Hypertens; 2013 Jun; 31(6):1256-64. PubMed ID: 23552127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Future perspectives and implications.
    Sleight P
    Int J Clin Pract Suppl; 2001 Jan; (117):22-3. PubMed ID: 11715355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood-pressure reduction and cardiovascular risk in HOPE study.
    Sleight P; Yusuf S; Pogue J; Tsuyuki R; Diaz R; Probstfield J;
    Lancet; 2001 Dec 22-29; 358(9299):2130-1. PubMed ID: 11784631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antecedent hypertension and the effect of captopril on the risk of adverse cardiovascular outcomes after acute myocardial infarction with left ventricular systolic dysfunction: Insights from the Survival and Ventricular Enlargement Trial.
    Kenchaiah S; Davis BR; Braunwald E; Rouleau JL; Dagenais GR; Sussex B; Steingart RM; Brown EJ; Lamas GA; Gordon D; Bernstein V; Pfeffer MA;
    Am Heart J; 2004 Aug; 148(2):356-64. PubMed ID: 15309009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.